Lv5
1360 积分 2024-01-31 加入
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma
2天前
已完结
Real-World Risk of Severe Cytopenias in Multiple Myeloma Patients Sequentially Treated with Immunomodulatory Drugs
2天前
已完结
Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: primary outcomes from the randomized phase III OLIGO study
1个月前
已完结
Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy
1个月前
已完结
Which drug would be more effective in treating patients with leptomeningeal metastases from breast cancer: intrathecal thiotepa or methotrexate?
1个月前
已完结
Vinorelbine thiotepa in metastatic breast cancer: a large real-life retrospective study
1个月前
已完结
A Pharmacokinetic and Dose Escalation Study of Pegfilgrastim (KRN125) in Lung Cancer Patients with Chemotherapy-induced Neutropenia
1个月前
已关闭
Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group
1个月前
已完结
Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review Study
1个月前
已完结
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
